DOC — Healthpeak Properties, Inc.

Healthpeak Properties, Inc. (DOC) Q4 2025 Earnings Call Summary

1. Key Financial Results and Metrics

• Q4 2025 Performance:

  • FFO as adjusted: $0.47 per share
  • AFFO: $0.40 per share
  • Same-store cash NOI growth: 3.9%

• Full Year 2025 Performance:

  • FFO as adjusted: $1.84 per share
  • AFFO: $1.69 per share
  • Total same-store cash NOI growth: 4%

• Portfolio Metrics:

  • Outpatient medical segment: 91% total occupancy, 4.9 million square feet leased (record for new leasing).
  • Lab segment: 77% total occupancy, 1.5% same-store growth.
  • Senior housing: 12.6% same-store growth, 17% growth in Q4.

2. Strategic Updates and Business Highlights

• Merger Benefits: The merger with Physicians Realty Trust has created significant synergies, totaling $70 million, enhancing the outpatient sector's performance.

• Outpatient Medical Growth: The ongoing shift to outpatient care and favorable policy changes are driving demand, with plans to sell non-core outpatient assets at favorable prices.

• Lab Segment Outlook: Recent improvements in capital raising and M&A activity signal potential recovery, with a focus on acquiring properties at attractive valuations.

• Senior Housing Spin-Off: Healthpeak plans to contribute its entire senior housing portfolio to a new entity, Janus Living, in an IPO aimed at maximizing shareholder value.

• Acquisition Activity: In 2026, Healthpeak has completed $464 million in acquisitions, including a $314 million buyout of a joint venture partner in senior housing.

3. Forward Guidance and Outlook

• 2026 Guidance:

  • FFO as adjusted expected to range from $1.70 to $1.74 per share.
  • Total same-store NOI growth projected to be between -1% to +1%.
  • Specific segment expectations: Outpatient medical (2%-3% growth), Lab (-5% to -10% decline), Senior housing (8%-12% growth).

• Transaction Activity: Healthpeak plans to pursue over $1 billion in asset sales and recapitalizations in 2026 to fund acquisitions and maintain liquidity.

4. Bad News, Challenges, or Points of Concern

• Lab Segment Decline: The lab segment faces challenges with a projected decline in same-store NOI due to occupancy loss and upcoming lease expirations, impacting earnings.

• Interest Rate Impact: Higher refinancing costs and interest rates are expected to pressure earnings, with a significant portion of debt maturing in the coming years.

• Occupancy Lag: There is a noted lag between lease expirations and financial impact, which may affect short-term earnings visibility.

5. Notable Q&A Insights

• Gateway Acquisition: Management expressed confidence in the Gateway acquisition, viewing it as a strategic opportunity to enhance their footprint in a prime market, despite current vacancies.

• Lab Segment Leasing Pipeline: The pipeline is improving, with a shift towards new leasing, but the average lease size and longer decision-making processes may slow immediate occupancy recovery.

• Senior Housing Transition: The transition to new operators in senior housing may lead to short-term occupancy declines, but management expects significant NOI growth potential over the next few years.

• Market Sentiment: Positive sentiment in the capital markets is noted, with expectations for continued improvement in leasing activity and tenant demand, particularly in the biotech sector.

This summary encapsulates Healthpeak's financial performance, strategic initiatives, future outlook, and challenges faced in Q4 2025, providing a comprehensive overview for stakeholders.